by Simona Gilman | Feb 6, 2020 | Events
This year’s State of Possible Conference, MassBio’s Annual Meeting, will celebrate what’s possible in our industry and for patients today that wasn’t five or 10 years ago. The two-day event will draw over 600 industry leaders from Massachusetts and beyond to...
by Simona Gilman | Feb 6, 2020 | Events
Artificial Intelligence (AI) and Machine Learning (ML) are rapidly transforming industries, from autonomous cars, to logistics, to technology – and now biotechnology. Excitement about AI and ML driven solutions for accelerated drug discovery, drug development, and...
by Simona Gilman | Feb 6, 2020 | Events
The future of medicine is data-driven and AI-enabled. Artificial intelligence will impact diagnosis, treatment decisions and patient care. Learn from others along the value-chain to understand how to effectively translate technology, data and analytic innovations into...
by gnsadmin | Nov 15, 2019 | Events, Featured Posts
On November 12 GNS Healthcare scientists were joined by Dr. Alan Venook of UCLA and the Alliance for Clinical Trials in Oncology to discuss understanding what drugs work for whom in the context of colorectal cancer. To view the webinar recording or download the...
by wpengine | Jun 26, 2019 | Events, Featured Posts
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at The Hill’s inaugural Future of Healthcare Summit to discuss the impact of technology on the transformation of care. Panelists included: Justin Barad, Co-Founder and CEO, Osso VR...
by wpengine | Jun 18, 2019 | Events
Colin Hill, CEO and Co-founder of GNS Healthcare, joined distinguished speakers at the Milken Institute Global Conference to discuss the impact of AI and machine learning on cancer medicine, including: Mike Nohaile, Senior Vice President of Strategy, Commercialization...
